Law Firm Investigates Element Solutions, Crinetics Pharmaceuticals and Solstice Advanced Materials Transactions
Law firm Halper Sadeh LLC is investigating Element Solutions Inc., Crinetics Pharmaceuticals, Inc., and Solstice Advanced Materials, Inc. for potential violations of securities laws related to ongoing merger and acquisition activities.
Halper Sadeh LLC, a law firm representing investors, announced on July 9, 2026, that it is investigating potential securities law violations and breaches of fiduciary duty concerning three companies: Element Solutions Inc (NYSE: ESI), Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), and Solstice Advanced Materials, Inc. (NASDAQ: SOLS).
The investigation includes Element Solutions' proposed sale to Solstice Advanced Materials, Inc. Under the terms, Element shareholders are to receive $10.00 in cash and 0.500 shares of Solstice common stock for each Element share. Post-transaction, Element shareholders are expected to hold approximately 44% of the combined entity.
Additionally, the firm is examining Crinetics Pharmaceuticals' sale to Vertex Pharmaceuticals Incorporated, where shareholders are offered $85.00 per share in cash. The merger between Solstice Advanced Materials, Inc. and Element Solutions is also under scrutiny.
Halper Sadeh LLC aims to ensure shareholders receive fair value and that transaction terms do not preclude superior offers. The firm encourages shareholders to contact them for a no-cost, no-obligation consultation regarding their rights and options, operating on a contingency fee basis where clients do not pay upfront legal fees.
The law firm has a history of representing investors in cases of securities fraud and corporate misconduct, having been instrumental in corporate reforms and recovering millions of dollars for defrauded investors.